NCT06223438View on ClinicalTrials.gov

Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.

CompletedOBSERVATIONAL
Enrollment

614

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

January 10, 2025

Conditions
Alzheimer DiseaseMCI
Trial Locations (1)

34711

K2 Medical Research South Orlando, Orlando

Sponsors

Lead Sponsor

Altoida
All Listed Sponsors
lead

Altoida

INDUSTRY

NCT06223438 - Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers. | Biotech Hunter | Biotech Hunter